A cannabis industry group calls President Donald Trump’s reclassification of state-licensed medical marijuana as a less-dangerous drug “the most significant federal advancement in cannabis policy” in

President Donald Trump’s decision to reclassify state-licensed medical marijuana as a less dangerous drug is a boon for the industry

The rescheduling action comes roughly four months after President Donald Trump signed an executive order directing the DOJ to pursue marijuana reclassification. The action is one of the most consequential federal marijuana policy changes in decades and could lend new legitimacy to regulated medical marijuana programs operating in more than 40 states.

The Justice Department said the drug will now be listed on Schedule III, similar to some common prescription painkillers. The order does not decriminalize marijuana for recreational use.

US News. US reclassifies some marijuana products as a less-dangerous drug. April 23, 2026. The U.S. Department of Justice said on Thursday (April 23) that it was immediately loose

The Trump administration on Thursday moved to reclassify marijuana as a less dangerous drug. Should the Drug Enforcement Administration approve the rescheduling request, it would mark a significant change in federal policy on marujuana,

The order from the Department of Justice moves state-licensed medical marijuana from a Schedule I drug to Schedule III, which is less restrictive.

President Donald Trump's administration has reclassified medical marijuana, which is already licensed in most states, as a less dangerous drug. The order signed Thursday by the nation’s acting attorney general is a first step toward broader federal acceptance of one of the nation's most commonly used drugs.